Table 1 Baseline demographics and data
From: Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis
Parameters | Average |
|---|---|
Age ± SD (min max) (years) | 63.2 ± 11.4 (32–85) |
Female, n (%) | 195 (91.1) |
Female over 60 years old, n (%) | 131 (61.1) |
BMI ± SD (min max) (kg/m2) | 21.3 ± 3.1 (12.3–30.0) |
HbA1c (NGSP) (min max) (%) | 5.65 ± 0.5 (4.6–9.2) |
DAS-ESR ± SD (min max) | 3.2 ± 1.1 (0.5–6.6) |
HAQ ± SD (min max) | 0.8 ± 0.7 (0–2.9) |
TSS ± SD (min max) | 122.6 ± 108.0 (0–443) |
MTX dose ± SD (mg) (min max) | 5.6 ± 3.9 (0–14) |
Steroid dose ± SD (mg) (min max) | 1.77 ± 2.62 (0–15) |
bDMARD use, n (%) | 67 (31.3) |
Bisphosphonate use, n (%) | 67(31.3) |
Vitamin D use, n (%) | 80(37.3) |
Observation period (min max) (years) | 2.3 (1.2–3.5) |
Lumbar spine BMD ± SD (min max) | 86.2 ± 18.3 (45.8–151.0) |
Total hip-BMD ± SD (min max) | 81.8 ± 14.3 (45.0–119.0) |
Distal forearm-BMD ± SD (min max) | 82.3 ± 22.0 (34.0–140.0) |
The annual lumbar spine-BMD change ± SD (min max) | − 0.14 ± 2.70 |
The annual total hip-BMD change ± SD (min max) | − 0.46 ± 1.63 |
The annual distal forearm-BMD change ± SD (min max) | − 1.15 ± 1.85 |
RF ± SD (min max) (U/ml) | 86.0 ± 129.4 (0–812.8) |
ACPA ± SD (min max) (U/ml) | 125.9 ± 113.5 (0–300) |
CRP ± SD (min max) (mg/dl) | 0.66 ± 1.32 (0–11.7) |
TRACP-5b ± SD (min max) (mU/dl) | 320.0 ± 149.0 (68–877) |
Homocysteine ± SD (min max) (nmol/ml) | 9.7 ± 3.5 (3.2–28.0) |
Uc-OC ± SD (ng/mL) (min max) | 4.8 ± 4.1 (0–23.3) |
BAP ± SD (μg/L) (min max) | 15.6 ± 6.4 (5.8–43.6) |
Urinary pentosidine ± SD(pg/ml)(min max) | 47.1 ± 25.9 (11.5–196.0) |